Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia
Crossref DOI link: https://doi.org/10.1007/s00198-016-3573-z
Published Online: 2016-03-30
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Naylor, K. E.
Jacques, R. M.
Peel, N. F. A.
Gossiel, F.
Eastell, R.
Funding for this research was provided by:
Eli Lilly and Company
Immunodiagnostic Systems
Text and Data Mining valid from 2016-03-30